Encapsulation, characterisation and in-vitro release of anti-tuberculosis drug using chitosan - poly ethylene glycol nanoparticles

International Journal of Pharmacy and Pharmaceutical Sciences

Volumn 4, Issue 4, 2012, Pages 255-259

  Rajan, M ^a   Raj, V ^a  

^a PERIYAR UNIVERSITY   (India)

Author keywords

Chitosan; Drug delivery; Nanoparticles; Polyethylene glycol; Rifampicin

Indexed keywords

CHITOSAN; MACROGOL 600; NANOPARTICLE; RIFAMPICIN; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG RELEASE; DRUG RETENTION; DRUG STABILITY; DRUG STRUCTURE; FOURIER TRANSFORM INFRARED PHOTOACOUSTIC SPECTROSCOPY; IN VITRO STUDY; MICELLE; NANOENCAPSULATION; PARTICLE SIZE; SCANNING ELECTRON MICROSCOPY; ZETA POTENTIAL;

EID: 84870898047     PISSN: None     EISSN: 09751491     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Martin FJ, Grove C Micro fabricated Drug Delivery Systems: Concepts to Improve Clinical. Biomedical Microdevices 2001; 3(2): 97-108.
2. Winzenburga G, Schmidt C, Fuchs S, Kissel T Biodegradable polymers and their potential use in parenteral veterinary drug delivery systems. Adv. Drug Delivery Rev 2004; 56: 1453-1466.
3. Gao Z, Fain HD, Rapoport N Ultrasound-Enhanced Tumor Targeting of Polymeric Micellar Drug Carriers. Mol. Pharmacol 2004; 4: 317-330.
4. Svenson S, Dendrimers for Enhanced Drug Solubilization. Nanomedicine 2008; 5: 679-702.
5. Antipov AA, Sukhorukov GB, Donath E, Mohwald H Sustained Release Properties of Polyelectrolyte Multilayer Capsules. J. Phys. Chem. B 2001; 105: 2281-2284.
6. Roy I, Ohulchansky TY, Pudavar HE, Bergey EJ, Oseroff AR, Morgan J, Dougherty TJ, Prasad PN Ceramic-Based Nanoparticles Entrapping Water-Insoluble Photosensitizing Anticancer Drugs: A Novel Drug-Carrier System for Photodynamic Therapy. J. Am. Chem. Soc 2003; 125: 7860-7865.
7. Lee LA, Wang Q Adaptations of Nanoscale Viruses and Other Protein Cages for Medical Applications. Nanomed.; Nanotechnol. Biol. Med 2006; 2: 137-149.
8. Cho K, Wang X, Nie S, Chen Z, Shin DM Therapeutic Nanoparticles for Drug Delivery in Cancer. Clin. Cancer Res 2008; 14: 1310-1316.
9. Vinogradov SV, Zeman AD, Batrakova EV, Kabanov AV Nanogel Formulations for Drug Delivery of Cytotoxic Nucleoside Analogs. J. Controlled Release 2005; 10: 143-157.
10. Schmid MH, Korting HC Therapeutic Progress with Topical Liposome Drugs for Skin Disease. Adv. Drug Delivery Rev 1996; 18: 335-342.
11. World Health Organization. 2010. Global tuberculosis control.
12. Li S, Vert M, Scott G Degradable polymers-Principles and applications (pp. 43-87.). Gilead, D. (Eds.), London: Chapman and Hall; 1994.
13. Juan Carlos Cabrera, Pierre Cambier, Pierre Van Cutsem Drug Encapsulation in Pectin Hydrogel Beads- A Systematic Study of Simulated Digestion Media. Int J Pharm Pharm Sci 3(5); 2011: 292-299.
14. Vishnu Vardhan Reddy B, Vinod Kumar KH, Rajeev Chandra, Subhash Chandra A, Dinesh Babu G, Chandra Prakash Preparation And In-Vitro Evaluation Of Ofloxacin Mucoadhesive Microsphere. Int J Pharm Pharm Sci 4(1); 2012: 93-96.
15. Zhang M, Li XH, Gong YD, Zhao NM, Zhang XF Properties and biocompatibility of chitosan films modified by blending with PEG. Biomaterials 2002; 23: 2641-2648.
16. Makino K, Nakajima T, Shikamura M, Ito F, Ando S, Kochi C, Inagawa H, Soma G, Terada H Efficient intracellular delivery of rifampicin to alveolar macrophages using rifampicin-loaded PLGA microspheres: effects of molecular weight and composition of PLGA on release of rifampicin. Colloids Surf B Biointerfaces 2004; 36: 35-42.
17. Sree H, Chandramouli R, Shobha R Ofloxacin targeting to lungs by way of microspheres. Int. J. Pharm 2009; 380: 127-132.
18. Tseng CL, Wang TW, Dong GC, Wu SYH, Young TH, Shieh MJ, Lou PJ, Lin FH Development of gelatin nanoparticles with biotinylated EGF conjugation for lung cancer targeting. Biomaterials 2007; 28: 3996-4005.
19. Chono S, Li SD, Conwell CC, Huang L An efficient and low immuno stimulatory nanoparticle formulation for systemic siRNA delivery to the tumor. J. Control. Release 2008; 131: 64-69.
20. Vyas SP, Quraishi S, Gupta S, Jaganathan KS Aerosolized liposomebased delivery of amphotericin B to alveolar macrophages. Int. J. Pharm 2005; 296: 12-25.
21. Torchilin VP Targeting of drugs and drug carriers within the cardiovascular system. Adv. Drug Deliver. Rev 1995; 17: 75-101.
22. Bar J, Herbst RS, Onn A Targeted drug delivery strategies to treat lung metastasis. Expert Opin. Drug Deliv 2009; 6: 1003-1016.
23. Zhang J, Li Q, Bai C, Han Y, Huang Y Inhalation of TGF-[beta]1 antibody: A new method to inhibit the airway stenosis induced by the endobronchial tuberculosis. Med. Hypotheses 2009; 73: 1065-1066.
24. Cohen T, Lipsitch M, Walensky RP, Murray M Beneficial and perverse effects of isoniazid preventive therapy for latent tuberculosis infection in HIV-tuberculosis coinfected populations. Proc. Natl. Acad. Sci. U.S.A 2006; 103: 7042.
25. Medoff G, Kobayashi GS, Kwan CN, Schlessinger D, Venkov P Proc. Natl. Acad. Sci. U.S.A 1972; 69: 196.
26. Zhang Y, Dhandayuthapani Y, Deretic V Molecular basis for the exquisite sensitivity of Mycobacterium tuberculosis to isoniazid. Proc. Natl. Acad. Sci. U.S.A 1996; 93: 13212-13216.
27. Dye C, Williams BG Criteria for the control of drug-resistant tuberculosis. Proc Natl Acad Sci U.S.A 2000; 97: 8180-8185.
28. Dickinson JM, Aber VR, Mitchison DA Bactericidal activity of streptomycin, isoniazid, rifampin, ethambutol, and pyrazinamide alone and in combination against Mycobacterium Tuberculosis. Am. Rev. Respir. Dis 1977; 116: 627.
29. Borba A, Gmez-Zavaglia A, Fausto R J. Phys. Chem. A 2009; 113: 9220.
30. Alteri CJ, Cortes JX, Hess S, Olin GC, Giron JA, Friedman RL Mycobacterium tuberculosis produces pili during human infection. Proc. Natl. Acad. Sci. U.S.A 2007; 104: 5145.
31. Moraski GC, Chang M Villegas-Estrada A Structure-activity relationship of new anti-tuberculosis agents derived from oxazoline and oxazole benzyl esters. Eur. J. Med. Chem 2010; 45: 1703.
32. Cavicchioli M, Massabni AC, Heinrich TA Pt(II) and Ag(I) complexes with acesulfame: crystal structure and a study of their antitumoral, antimicrobial and antiviral activities. J. Inorg. Biochem 2010; 104: 533.
33. Luciani F, Sisson SA, Jiang H, Francis AR, Tanaka MM The epidemiological fitness cost of drug resistance in Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. U.S.A 2009; 106: 14711.
34. Bahr W, Stender W, Scheit KH, Jovin TM RNA polymerase; Cold Spring Harbor. New York; 1976.
35. Campbell EA, Korzheva N, Mustaev A, Murakami K, Nair S, Goldfarb A, Darst SA Structural mechanism for rifampicin inhibition of bacterial RNA polymerase. Cell 2001; 104: 901-912
36. Huwyler J, Wu D, Pardridge WM Drug Transport to Brain with Targeted Liposomes. Proc. Natl. Acad. Sci. U.S.A 1996; 93: 14164.
37. Hu FQ, Meng P, Dai YQ, Du YZ, You J, Wei XH, Yuan H PEGylated chitosan-based polymer micelle as an intracellular delivery carrier for anti-tumor targeting therapy. Eur. J. Pharm. Biopharm 2008; 70: 749-757.
38. Liebler JM, Markin CJ Fiberoptic Bronchoscopy for Diagnosis and Treatment. Crit. Care Clin 2000; 16: 83-100.
39. Heller J Fundamentals of polymer science. Robinson JR, Lee VH Editors. Controlled drug delivery fundamentals and applications. New York: Marcel Dekker; 1987. pp.139-212.
40. Chiou WL, Riegelman S Pharmaceutical applications of solid dispersion systems. J. Pharm. Sci 1971; 60: 1281-1302.
41. Ford JL The current status of solid dispersions. Pharm. Acta Helv 1986; 61: 69-88.
42. Xu HY, Kaar JL, Russell AJ, Wagner WR Characterizing the modification of surface proteins with poly(ethylene glycol) to interrupt platelet adhesion. Biomaterials 2006; 27: 3125-35.
43. Mahoney JM, Anseth KS Three-dimensional growth and function of neutral tissue in degradable polyethylene glycol hydrogels. Biomaterials 2006; 27: 2265-74.
44. Li PW, Wang YC, Zeng FB, Chen LJ, Peng Z, Kong LX Synthesis and characterization of folate conjugated chitosan and cellular uptake of its nanoparticles in HT-29 cells. Carbohydrate Research 2011; 346: 801-806.
45. Puwang LI, Yichao Wang, Zheng Peng, Fenghua She, Lingxue Kong Development of chitosan nanoparticles as drug delivery systems for 5-fluorouracil and leucovorin blends. Carbohydrate Polymers 2011; 85: 698-704.
46. Papadimitriou S, Bikiaris D, Avgoustakis K, Karavas E, Georgarakis M Chitosan nanoparticles loaded with dorzolamide and pramipexole. Carbohydrate Polymers 2008; 73: 44-54.
47. Calvo P, Remunanlopez C, Vilajato JL, Alonso MJ Novel hydrophilic chitosan-polyethylene oxide nanoparticles as protein carriers. Journal of Applied Polymer Science 1997; 63: 125-132.
48. Abdulla JMA, Yvonne Tze-Fung Tan, Yusrida Darwis Rehydrated Lyophilized Rifampicin-Loaded mPEG-DSPE Formulations for Nebulization. AAPS PharmSciTech 2010; 11(2): 663-671.
49. Agrawal S, Ashokraj Y, Bharatam PV, Pillai O, Panchagnula R Solidstate characterization of rifampicin samples and its biopharmaceutic relevance. Eur J Pharm Sci 2004; 22(2-3): 127-44.